D-0817-2018 Class II Terminated

Recalled by Perrigo New York — Bronx, NY

FDA drug recall D-0817-2018 was initiated by Perrigo New York on May 7, 2018 and is designated Class II. Reason for recall: Failed Stability Specifications The recall status is terminated (terminated Dec 10, 2018). Affected quantity: 571,632 tubes.

Recall details

Product Type
Drugs
Report Date
May 23, 2018
Initiation Date
May 7, 2018
Termination Date
Dec 10, 2018
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
571,632 tubes

Product description

Hydrocortisone Ointment, USP 2.5%, Net Wt. 20g, Rx Only, Manufactured By Perrigo, Bronx, NY 10457, Distributed by Perrigo, Allegan MI 49010, NDC 45802-014-02

Reason for recall

Failed Stability Specifications

Distribution pattern

US Nationwide including Puerto Rico.

Code information

Lot Numbers: 7AT0283V, exp. 11/18 7AT0284V, exp. 11/18 7AT0285V, exp. 11/18 7FT0460, exp. 05/19 7FT0461, exp. 05/19 7GT0465, exp. 06/19 7GT0466, exp. 06/19 7JT0390, exp. 08/19 7JT0392, exp. 08/19 7KT0588, exp. 09/19 7KT0589, exp. 09/19

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0817-2018
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0817-2018. Report a data issue: hello@regdatalab.com.